Abbott Vascular has restricted the use of its Absorb and Absorb GT1 bioresorbable vascular scaffolds (BVS) in Europe to clinical registries.

New findings on how cardiac muscle cells are damaged during surgery could point to emerging methods that will allow hearts to recover more quickly.

Researchers from Case Western Reserve University have found a new target for drug developers looking for ways to improve cardiac function in heart failure patients.

A new survey organized by the American Heart Association (AHA) found that only half of Americans would be willing to perform cardiopulmonary resuscitation (CPR) in an emergency because of fears that they wouldn’t do it correctly.

To better treat patients with aortic valve disease, J. Scott Rankin, MD, a surgeon at the West Virginia University Heart and Vascular Institute in Morgantown has developed the HAART 300 Aortic Annuloplasty Device—and it just received approval U.S. Food and Drug Administration this week.

Stuart Long, a veteran medical device executive, has been hired as CEO of InfoBionic.

In early 2012, hospitals in New York received reports from the state on their inappropriate PCI rates. The state later published the rates in a medical journal and recommended that payers deny reimbursement for inappropriate PCIs in Medicaid patients.

The U.S. Food and Drug Administration (FDA) has approved a new study that will test the efficacy of a stem cell technique used on children suffering from congenital heart disease.